๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Thyroid Eye Disease

Thyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis NCT06963203n/a15 sites๐Ÿ“ Aalst๐Ÿ“ Nancy๐Ÿ“ Athens Andrea Goldmann In Vivo CAR-T for Refractory Graves' Disease NCT07333677EARLY Phase 11 site๐Ÿ“ Shanghai Shanghai Zhongshan Hospital ยท Tests: In Vivo CAR-T Therapy A Study of GenSci098 in Subjects With Active Thyroid Eye Disease NCT06569758Phase 11 site๐Ÿ“ Shanghai Changchun GeneScience Pharmaceutical Co., Ltd. ยท Tests: GenSci098, GenSci098 Placebo Screening, Classification, and Outcome Prediction Ensemble Using Orbital MRI for Thyroid Eye Disease: The TED SCOPE National Multicenter Registry Study NCT07716397n/a1 site๐Ÿ“ Shanghai Shanghai Changzheng Hospital ยท Tests: MRI scan๏ผŒocular ultrasound Validating Immunological Markers Associated With Mental Fatigue in Graves' Disease NCT06081439n/a1 site๐Ÿ“ Gothenburg Vastra Gotaland Region A Study of Teprotumumab N01 in Subjects With Active Thyroid Eye Disease NCT07265258Phase 41 site๐Ÿ“ Shanghai Innovent Biologics (Suzhou) Co. Ltd. ยท Tests: Teprotumumab N01, Methylprednisolone Hydroxychloroquine in Mild Graves' Orbitopathy NCT05126147Phase 42 sites๐Ÿ“ Hsinchu๐Ÿ“ Taipei National Taiwan University Hospital ยท Tests: Hydroxychloroquine A Clinical Study of Cizutamig in Thyroid Eye Disease NCT07597200Phase 114 sites๐Ÿ“ Hefei๐Ÿ“ Beijing๐Ÿ“ Fuzhou Candid Therapeutics ยท Tests: Cizutamig will be dosed according to the protocol. Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer NCT05999630Phase 31 site๐Ÿ“ Nashville Vanderbilt University Medical Center ยท Tests: Artificial Tears Methylcellulose DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study NCT01247597n/a2 sites๐Ÿ“ Bethesda๐Ÿ“ Rockville National Cancer Institute (NCI) Study of BHV-1300 in Graves' Disease NCT06980649Phase 118 sites๐Ÿ“ South Gate๐Ÿ“ Miami๐Ÿ“ Columbus Biohaven Therapeutics Ltd. ยท Tests: BHV-1300 The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment. NCT07152340Phase 42 sites๐Ÿ“ Changhua๐Ÿ“ Shanghai Shanghai Changzheng Hospital ยท Tests: IBI311, Glucocorticoids Treatment of Chronic Thyroid Eye Disease With MHB018A NCT07622121Phase 31 site๐Ÿ“ Coral Gables Minghui Pharmaceutical (Hangzhou) Ltd ยท Tests: MHB018A injection, MHB018A injection Placebo A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease NCT06727604Phase 2134 sites๐Ÿ“ Phoenix๐Ÿ“ Phoenix๐Ÿ“ Huntington Beach Immunovant Sciences GmbH ยท Tests: IMVT-1402, IMVT-1402, Placebo Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye Disease NCT07547930Phase 21 site๐Ÿ“ Xiamen The First Affiliated Hospital of Xiamen University ยท Tests: Tofacitinib Systemic Inflammation, Thyroid Autoimmunity and Neuroretinal Changes in Graves Disease NCT07480720n/a1 site๐Ÿ“ ElรขzฤฑฤŸ Elazฤฑg Fethi Sekin Sehir Hastanesi A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease. NCT07596849Phase 342 sites๐Ÿ“ Aalst๐Ÿ“ Ghent๐Ÿ“ Pazardzhik argenx ยท Tests: efgartigimod PH20 SC, Placebo PH20 SC The Impact of Person Centred Care (PCC) in Grave's Disease NCT06309316NA1 site๐Ÿ“ Gothenburg Vastra Gotaland Region ยท Tests: Person-centred care (PCC) Bimatoprost as a Treatment for Graves' Orbitopathy NCT03708627EARLY Phase 11 site๐Ÿ“ Seattle Johns Hopkins University ยท Tests: Bimatoprost Ophthalmic A Clinical Follow-up Study on Drug Therapy for Graves' Disease Patients in China NCT07040306n/a1 site๐Ÿ“ Shenyang First Hospital of China Medical University ยท Tests: Methimazole(MMI) Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites๐Ÿ“ Sioux Falls๐Ÿ“ Sydney Sanford Health Establishment of Multiparametric Prediction Models for Moderate to SevereThyroid Associated Ophthalmopathy NCT06590220n/a1 site๐Ÿ“ Shanghai Shanghai Changzheng Hospital Prevalence and Predictors of Incidental Thyroid Carcinoma in Patients With Graves' Disease Undergoing Thyroidectomy. NCT07059507n/a1 site๐Ÿ“ Minya Minia University ยท Tests: Total thyroidectomy A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease NCT07018323Phase 2163 sites๐Ÿ“ Tucson๐Ÿ“ Concord๐Ÿ“ Aurora Immunovant Sciences GmbH ยท Tests: IMVT-1402, IMVT-1402, Placebo Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease NCT07682896Phase 229 sites๐Ÿ“ Gilbert๐Ÿ“ Phoenix๐Ÿ“ Tucson Yarrow Bioscience, Inc. ยท Tests: Experimental: YB-101, Placebo YB-101 A Study of IBI3031 in Participants With Thyroid Eye Disease NCT07622368Phase 11 site๐Ÿ“ Shenyang Innovent Biologics (Suzhou) Co. Ltd. ยท Tests: IBI3031, placebo Orbital Radiotherapy in Grave's Ophthalmopathy 1 Week vs 2 Weeks (OraGO-1 Trial) NCT06392906Phase 31 site๐Ÿ“ Bangkok Noi Janjira Petsuksiri ยท Tests: Short course radiation therapy, Standard course radiation therapy Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease NCT07400757NA1 site๐Ÿ“ Taipei Taipei Veterans General Hospital, Taiwan ยท Tests: Atorvastatin (Lipitor), Vitamin D Eye Tracking Study on Eye Movement Function and Visual Attention Patterns in Patients With Thyroid-Associated Ophthalmopathy NCT07381413n/a1 site๐Ÿ“ Shanghai Shanghai Changzheng Hospital ยท Tests: Non-invasive Eye Tracking Assessment Allogeneic Anti-CD19 CAR-T for Refractory Graves' Disease NCT07129642EARLY Phase 11 site๐Ÿ“ Shanghai Shanghai Zhongshan Hospital ยท Tests: Allogeneic CAR-T
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy